Drug Maker Hit With Stock Drop Suit Over Fibrotic Disease Treatment Drug
BOSTON — An investor filed a securities class action lawsuit against a pharmaceutical company and two of its senior officers on March 12, alleging that the defendants misrepresented the clinical trial...To view the full article, register now.
Already a subscriber? Click here to view full article